Ginkgo Bioworks Holdings, Inc. (DNA)
7.225
-0.32
(-4.18%)
USD |
NYSE |
Aug 26, 16:00
7.225
0.00 (0.00%)
After-Hours: 16:05
Ginkgo Bioworks Holdings Gross Profit Margin (Quarterly) : 30.37% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.37% |
| March 31, 2026 | 18.37% |
| December 31, 2025 | 51.30% |
| September 30, 2025 | 30.56% |
| June 30, 2025 | 47.29% |
| March 31, 2025 | 50.53% |
| December 31, 2024 | 53.08% |
| September 30, 2024 | 67.24% |
| June 30, 2024 | 44.76% |
| March 31, 2024 | 41.83% |
| December 31, 2023 | 54.11% |
| September 30, 2023 | 42.02% |
| Date | Value |
|---|---|
| June 30, 2023 | 55.63% |
| March 31, 2023 | 48.78% |
| December 31, 2022 | 35.65% |
| September 30, 2022 | 49.44% |
| June 30, 2022 | 49.16% |
| March 31, 2022 | 43.64% |
| December 31, 2021 | 52.67% |
| September 30, 2021 | 65.08% |
| June 30, 2021 | 44.37% |
| March 31, 2021 | 33.49% |
| December 31, 2020 | 44.33% |
| September 30, 2020 | 73.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sotera Health Co. | 54.44% |
| Caris Life Sciences, Inc. | 68.10% |
| BillionToOne, Inc. | 70.45% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.94% |
| Return on Assets | -26.50% |
| Return on Invested Capital | -31.70% |
| Profit Margin (Quarterly) | -284.4% |
| Operating Margin (Quarterly) | -285.0% |
| Return on Net Operating Assets | -48.49% |